FluroTech Identifies Six Sites For Its High Volume COVID-19 Antigen Test Trial

FluroTech Ltd. (TSXV: TEST) and its subsidiary FluroTest Diagnostics Systems announced today that the clinical trials for its high volume COVID-19 rapid antigen testing system are pushing to its next phase. This trial is being conducted with contract research organization Toolbox Medical Innovations.

FluroTest reported that approximately 600 volunteer participants are currently being identified from six clinical sites across California, Texas, Colorado, Rhode Island, and Florida for the next phase of the trial. The participants are a mix of symptomatic and asymptomatic individuals and the identified sites will compare the diagnostic results from the company’s high volume antigen testing system and a comparator RT-PCR assay.

As reported previously, the clinical trial results will be used to apply for an emergency use authorization from the U.S. FDA and an interim order authorization from the Health Canada.

FluroTech Ltd. last traded at $0.31 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study

Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from...

Tuesday, December 7, 2021, 11:21:00 AM

Tesla Stops Nearly All Production at Shanghai Factory Amid Parts Shortages

Tesla (NASDAQ: TSLA) has reportedly suspended nearly all production at its Shanghai factory, after running...

Tuesday, May 10, 2022, 05:04:00 PM

YouTube Updates Misinformation Policies, Will Remove Content on Covid-19 Myths, Alternative Cancer Treatments

Earlier this week, YouTube unveiled a refined policy aimed at curbing medical misinformation on its...

Saturday, August 19, 2023, 07:18:00 AM

US Thanksgiving Air Travel Rebounds to Highest Level Since Beginning of Pandemic– But Still Nearly 50% Below 2019 Traffic

Despite the CDC warning Americans against travelling for the Thanksgiving holiday amid soaring Covid-19 infection...

Monday, November 30, 2020, 03:33:00 PM

Selling COVID-19 Test Kits In Canada – The Daily Dive feat Marshall Gunter of Datametrex AI

This afternoon on The Daily Dive, Marshall Gunter, CEO of Datametrex AI (TSXV: DM) joins...

Thursday, December 17, 2020, 01:00:00 PM